Twenty-Five Hours of Fasting with Automated Insulin Delivery in Youth with Type 1 Diabetes

<b><i>Introduction and Objective:</i></b> Fasting presents unique metabolic challenges for individuals with T1D. The 25-h Yom Kippur complete fast provides an opportunity to evaluate whether automated insulin delivery (AID) systems can maintain metabolic stability, prevent hypoglycemia and ketosis, and determine basal insulin requirements during prolonged fasting. <b><i>Methods:</i></b> This real-world, noninterventional study included 54 adolescents and young adults with T1D (mean age 17.3 ± 3.3 years, HbA1c 6.8 ± 1.0%). Participants used MiniMed 780 G (<i>n</i> = 34), Control-IQ (<i>n</i> = 10), or open-source AID systems (<i>n</i> = 10). Common system-specific adjustments included setting a 150 mg/dL exercise target, activating sleep mode, and modifying basal or glucose targets, while 11 participants made no changes. Ketone levels were measured after the 25-h fast and a routine overnight fast. Analyses compared glucose and insulin across fasting periods and different 780 G settings and assessed predictors of hypoglycemia and ketone levels. <b><i>Results:</i></b> All participants successfully completed the fast. Mean TIR increased from 71.6 ± 13.9% during routine days to 82 ± 13.2% during fasting (<i>P</i> < 0.01), while time <70 mg/dL decreased from 2.6% to 2.2% (<i>P</i> = 0.017). Ten mild hypoglycemic events occurred after the pre-fast meal and one during fasting. A higher baseline percentage of time <70 mg/dL was the only predictor of hypoglycemia. No significant difference was found between 780 G users with exercise mode and those with no or minor changes. Participants received 43.4 ± 16.8% (range 9.3%-90%) of their usual insulin dose. Median (IQR) end-of-fast ketone levels were 0.4 (0.3, 0.7) mmol/L vs 0.1 (0, 0.1) mmol/L on a regular morning (<i>n</i> = 31); insulin doses <30% of usual dose were associated with higher ketone levels. No severe hypoglycemia or serious adverse events occurred. <b><i>Conclusion:</i></b> AID systems enable safe 25-h fasting by maintaining glucose control and reducing the risk of hypoglycemia and ketonuria. Fasting adjustments should be individualized and can often be minor.

Authors

Institutions

Publication Details

Journal
Diabetes Technology & Therapeutics
Published
2025-12-30
DOI
https://doi.org/10.1177/15209156251407705
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Twenty-Five Hours of Fasting with Automated Insulin Delivery in Youth with Type 1 Diabetes

Sari Krepel Volsky, Keren Smuel-Zilberberg, Rachel Bello, Moshe Phillip et al.
Diabetes Technology & Therapeutics
Diabetes Management and Research
article

Twenty-Five Hours of Fasting with Automated Insulin Delivery in Youth with Type 1 Diabetes

Sari Krepel Volsky, Keren Smuel-Zilberberg, Rachel Bello, Moshe Phillip, Naama Fisch-Shvalb, Michal Yackobovitch-Gavan, Revital Nimri
article en

Abstract

<b><i>Introduction and Objective:</i></b> Fasting presents unique metabolic challenges for individuals with T1D. The 25-h Yom Kippur complete fast provides an opportunity to evaluate whether automated insulin delivery (AID) systems can maintain metabolic stability, prevent hypoglycemia and ketosis, and determine basal insulin requirements during prolonged fasting. <b><i>Methods:</i></b> This real-world, noninterventional study included 54 adolescents and young adults with T1D (mean age 17.3 ± 3.3 years, HbA1c 6.8 ± 1.0%). Participants used MiniMed 780 G (<i>n</i> = 34), Control-IQ (<i>n</i> = 10), or open-source AID systems (<i>n</i> = 10). Common system-specific adjustments included setting a 150 mg/dL exercise target, activating sleep mode, and modifying basal or glucose targets, while 11 participants made no changes. Ketone levels were measured after the 25-h fast and a routine overnight fast. Analyses compared glucose and insulin across fasting periods and different 780 G settings and assessed predictors of hypoglycemia and ketone levels. <b><i>Results:</i></b> All participants successfully completed the fast. Mean TIR increased from 71.6 ± 13.9% during routine days to 82 ± 13.2% during fasting (<i>P</i> < 0.01), while time <70 mg/dL decreased from 2.6% to 2.2% (<i>P</i> = 0.017). Ten mild hypoglycemic events occurred after the pre-fast meal and one during fasting. A higher baseline percentage of time <70 mg/dL was the only predictor of hypoglycemia. No significant difference was found between 780 G users with exercise mode and those with no or minor changes. Participants received 43.4 ± 16.8% (range 9.3%-90%) of their usual insulin dose. Median (IQR) end-of-fast ketone levels were 0.4 (0.3, 0.7) mmol/L vs 0.1 (0, 0.1) mmol/L on a regular morning (<i>n</i> = 31); insulin doses <30% of usual dose were associated with higher ketone levels. No severe hypoglycemia or serious adverse events occurred. <b><i>Conclusion:</i></b> AID systems enable safe 25-h fasting by maintaining glucose control and reducing the risk of hypoglycemia and ketonuria. Fasting adjustments should be individualized and can often be minor.

Diabetes Technology & Therapeutics
Tel Aviv University (IL), Schneider Children's Medical Center (IL)
Openalex Percentile: Top 29%
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.